Healthcare -
Biotechnology - NASDAQ - US
$ 13.49
-0.369 %
$ 195 M
Market Cap
0.11
P/E
INBX - LONG-TERM DEBT
Long-term Debt INBX - Inhibrx Biosciences, Inc.
208 M
LAST VALUE
71.83%
2 YEAR CAGR
125.57%
5 YEAR CAGR
0.00%
10 YEAR CAGR